Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Total Liabilities (2016 - 2026)

Usana Health Sciences has reported Total Liabilities over the past 17 years, most recently at $144.2 million for Q2 2026.

  • Quarterly Total Liabilities fell 11.4% to $144.2 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $144.2 million through Apr 2026, down 11.4% year-over-year, with the annual reading at $156.6 million for FY2026, 3.22% down from the prior year.
  • Total Liabilities was $144.2 million for Q2 2026 at Usana Health Sciences, down from $156.6 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $183.0 million in Q2 2022 and troughed at $119.2 million in Q2 2024.
  • The 5-year median for Total Liabilities is $147.0 million (2025), against an average of $149.1 million.
  • Year-over-year, Total Liabilities fell 19.4% in 2022 and then rose 25.86% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $162.1 million in 2022, then decreased by 16.36% to $135.6 million in 2023, then grew by 19.41% to $161.9 million in 2024, then decreased by 10.39% to $145.0 million in 2025, then fell by 0.59% to $144.2 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Total Liabilities are $144.2 million (Q2 2026), $156.6 million (Q1 2026), and $145.0 million (Q3 2025).